ECIAOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
ENCISION INC
Financials through Q2 FY2026, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 13, 2025
$0.01+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $163.15K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.2685 (−95.89%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
ENCISION INC saw revenue fall 3.0% to $6.30M over the twelve months to Sep 30, 2025. Free cash flow was -$544.87K, down 290.8% from a year earlier.
Revenue
$6.30M
-3.0% vs. a year earlier
Operating income
-$319.68K
TTM Q2 2026
Free cash flow
-$544.87K
-290.8% vs. a year earlier
EPS, diluted
-$0.02
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2025
Valuation
- Market cap
- $163.15K
- P/E ratio
- –
- Price to sales
- 0.03
- Price to book
- 0.09
- Dividend yield
- –
- Free cash flow yield
- -333.96%
Fundamentals
- Revenue
- $6.30M
- Net income
- -$380.94K
- EPS, diluted
- -$0.02
- Free cash flow
- -$544.87K
- Book value per share
- $0.13
- Diluted shares
- 14M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$6.30M-3.0% YoY
Gross profit
$3.32M+4.2% YoY
Operating income
-$319.68K
Net income
-$380.94K
EPS, diluted
-$0.02
Free cash flow
-$544.87K-290.8% YoY
Reported periodTrailing twelve months